Form 8-K - Current report:
SEC Accession No. 0001140361-25-017356
Filing Date
2025-05-05
Accepted
2025-05-05 16:45:23
Documents
15
Period of Report
2025-05-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20048420_8k.htm   iXBRL 8-K 35524
2 EXHIBIT 99.1 ef20048420_ex99-1.htm EX-99.1 24925
6 GRAPHIC image00001.jpg GRAPHIC 3465
  Complete submission text file 0001140361-25-017356.txt   208924

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vtrs-20250505.xsd EX-101.SCH 3979
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vtrs-20250505_lab.xml EX-101.LAB 21966
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vtrs-20250505_pre.xml EX-101.PRE 16042
17 EXTRACTED XBRL INSTANCE DOCUMENT ef20048420_8k_htm.xml XML 4055
Mailing Address 1000 MYLAN BOULEVARD CANONSBURG PA 15317
Business Address 1000 MYLAN BOULEVARD CANONSBURG PA 15317 (724) 514-1465
Viatris Inc (Filer) CIK: 0001792044 (see all company filings)

EIN.: 834364296 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39695 | Film No.: 25913660
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)